Palladin expression is a conserved characteristic of the desmoplastic tumor microenvironment and contributes to altered gene expression

Cytoskeleton

Volumn 72, Issue 8, 2015, Pages 402-411

  Cannon, Austin R ^a   Owen, Meredith K ^a,b   Guerrero, Michael S ^a,b   Kerber, Michael L ^a,b   Goicoechea, Silvia M ^c   Hemstreet, Kathryn C ^a   Klazynski, Brian ^a   Hollyfield, Johnathan ^a   Chang, Emily H ^a   Hwang, Rosa F ^d   Otey, Carol A ^a,b   Kim, Hong Jin ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c UNIVERSITY OF TOLEDO   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Adenocarcinoma; Cancer associated fibroblast; Myofibroblast; Pancreas cancer; Tumor associated fibroblast

Indexed keywords

COLLAGEN; ONCOPROTEIN; PALLADIN; PALLADIN 75; PALLADIN ISOFORM 4; POLYCLONAL ANTIBODY; RNA; UNCLASSIFIED DRUG; CYTOSKELETON PROTEIN; ISOPROTEIN; PALLADIN PROTEIN, HUMAN; PHOSPHOPROTEIN;

ADENOCARCINOMA; ARTICLE; BIOSYNTHESIS; CANCER CELL; CANCER TISSUE; CELL FRACTIONATION; COLON ADENOCARCINOMA; CONTROLLED STUDY; CYTOPLASM; EXTRACELLULAR MATRIX; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SOLID TUMOR; STOMACH ADENOCARCINOMA; STROMA; TUMOR MICROENVIRONMENT; CHEMISTRY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PANCREAS TUMOR; TUMOR CELL CULTURE;

ADENOCARCINOMA; CYTOSKELETAL PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; PANCREATIC NEOPLASMS; PHOSPHOPROTEINS; PROTEIN ISOFORMS; TUMOR CELLS, CULTURED; TUMOR MICROENVIRONMENT;

EID: 84943664037     PISSN: 19493584     EISSN: 19493592     Source Type: Journal    
DOI: 10.1002/cm.21239     Document Type: Article

References (38)

1. Beck MR, Dixon RD, Goicoechea SM, Murphy GS, Brungardt JG, Beam MT, Srinath P, Patel J, Mohiuddin J, Otey CA, and Campbell SL. 2013. Structure and function of palladin's actin binding domain. J Mol Biol 425:3325-3337.
2. Boukhelifa M, Hwang S, Valtschanoff JG, Meeker RB, Rustioni A, Otey CA. 2003. A critical role for palladin in astrocyte morphology and response to injury. Mol Cell Neurosci 23:661-668.
3. Brentnall TA, Lai LA, Coleman J, Bronner MP, Pan S, Chen R. 2012. Arousal of cancer-associated stromal fibroblasts: palladin-activated fibroblasts promote tumor invasion. PLoS One 7:e30219.
4. Brown MC, Joaquim TR, Chambers R, Onisk DV, Yin F, Moriango JM, Xu Y, Fancy DA, Crowgey EL, He Y, Stave JW, Lindpaintner K. 2011. Impact of immunization technology and assay application on antibody performance-a systematic comparative evaluation. PLoS One 6:e28718.
5. Carmona-Saez P, Chagoyen M, Tirado F, Carazo JM, Pascual-Montano A. 2007. GENECODIS: a web-based tool for finding significant concurrent annotations in gene lists. Genome Biol 8:R3. doi:10.1186/gb-2007-8-1-r3.
6. Chang EH, Gasim AH, Kerber ML, Patel JB, Glaubiger SA, Falk RJ, Jennette JC, Otey CA. 2015. Palladin is upregulated in kidney disease and contributes to epithelial cell migration after injury. Sci Rep 5:7695.
7. De Wever O, Mareel M. 2003. Role of tissue stroma in cancer cell invasion. J Pathol 200:429-447.
8. Endlich N, Schordan E, Cohen CD, Kretzler M, Lewko B, Welsch T, Kriz W, Otey CA, Endlich K, The European Renal cDNA Bank Consortium. 2009. Palladin is a dynamic actin-associated protein in podocytes. Kidney Int 75:214-226.
9. Goicoechea SM, Bednarski B, Stack C, Cowan DW, Volmar K, Thorne L, Cukierman E, Rustgi AK, Brentnall T, Hwang RF, McCulloch CA, Yeh JJ, Bentrem DJ, Hochwald SN, Hingorani SR, Kim HJ, Otey CA. 2010. Isoform-specific upregulation of palladin in human and murine pancreas tumors. PLoS One 5:e10347.
10. Goicoechea SM, Garcia-Mata R, Staub J, Valdivia A, Sharek L, McCulloch CG, Hwang RF, Urrutia R, Yeh JJ, Kim HJ, Otey CA. 2014. Palladin promotes invasion of pancreatic cancer cells by enhancing invadopodia formation in cancer-associated fibroblasts. Oncogene 33:1265-1273.
11. Gupta V, Bassi DE, Simons JD, Devarajan K, Al-Saleem T, Uzzo RG, Cukierman E. 2011. Elevated expression of stromal palladin predicts poor clinical outcome in renal cell carcinoma. PLoS One 6:e21494.
12. Hamada S, Masamune A, Shimosegawa T. 2013. Novel therapeutic strategies targeting tumor-stromal interactions in pancreatic cancer. Front Physiol 4:331.
13. Hanahan D, Weinberg RA. 2011. Hallmarks of cancer: the next generation. Cell 144:646-674.
14. Huang da W, Sherman BT, Lempicki RA. 2009a. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4:44-57.
15. Huang da W, Sherman BT, Lempicki RA. 2009b. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 37:1-13.
16. Hwang RF, Moore T, Arumugam T, Ramachandran V, Amos KD, Rivera A, Ji B, Evans DB, Logsdon CD. 2008. Cancer-associated stromal fibroblasts promote pancreatic tumor progression. Cancer Res 68:918-926.
17. Jin L, Yoshida T, Ho R, Owens GK, Somlyo AV. 2009. The actin-associated protein Palladin is required for development of normal contractile properties of smooth muscle cells derived from embryoid bodies. J Biol Chem 284:2121-2130.
18. Jin L, Gan Q, Zieba BJ, Goicoechea SM, Owens GK, Otey CA, Somlyo AV. 2010. The actin associated protein palladin is important for the early smooth muscle cell differentiation. PLoS One 5:e12823.
19. Kharaishvili G, Simkova D, Bouchalova K, Gachechiladze M, Narsia N, Bouchal J. 2014. The role of cancer-associated fibroblasts, solid stress and other microenvironmental factors in tumor progression and therapy resistance. Cancer Cell Int 14:41.
20. MacEwen EG, Pastor J, Kutzke J, Tsan R, Kurzman ID, Thamm DH, Wilson M, Radinsky R. 2004. IGF-1 receptor contributes to the malignant phenotype in human and canine osteosarcoma. J Cell Biochem 92:77-91.
21. Mao Y, Keller ET, Garfield DH, Shen K, Wang J. 2013. Stromal cells in tumor microenvironment and breast cancer. Cancer Metastasis Rev 32:303-315.
22. McLane JS, Ligon LA. 2015. Palladin mediates stiffness-induced fibroblast activation in the tumor microenvironment. Biophys J. 109:249-264.
23. Mueller MM, Fusenig NE. 2004. Friends or foes - bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 4:839-849.
24. Murphy SL, Xu J, Kochanek KD. 2013. Deaths: final data for 2010. Natl Vital Stat Rep 61:1-117.
25. Mykkänen OM, Grönholm M, Rönty M, Lalowski M, Salmikangas P, Suila H, Carpén O. 2001. Characterization of human palladin, a microfilament-associated protein. Mol Biol Cell 12:3060-3073.
26. Neesse A, Krug S, Gress TM, Tuveson DA, Michl P. 2013. Emerging concepts in pancreatic cancer medicine: targeting the tumor stroma. Onco Targets Ther 7:33-43.
27. Neuzillet C, Tijeras-Raballand A, Cohen R, Cros J, Faivre S, Raymond E, de Gramont A. 2014. Targeting the TGFbeta pathway for cancer therapy. Pharmacol Ther 147:22-31.
28. Niedenberger BA, Chappell VK, Kaye EP, Renegar RH, Geyer CB. 2013. Nuclear localization of the actin regulatory protein Palladin in sertoli cells. Mol Reprod Dev 80:403-413.
29. Niedenberger BA, Chappell VA, Otey CA, Geyer CB. 2014. Actin dynamics regulate subcellular localization of the F-actin-binding protein PALLD in mouse Sertoli cells. Reproduction 148:333-341.
30. Ohuchida K, Mizumoto K, Murakami M, Qian LW, Sato N, Nagai E, Matsumoto K, Nakamura T, Tanaka M. 2004. Radiation to stromal fibroblasts increases invasiveness of pancreatic cancer cells through tumor-stromal interactions. Cancer Res 64:3215-3222.
31. Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, Carey VJ, Richardson AL, Weinberg RA. 2005. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121:335-348.
32. Özdemir BC, Pentcheva-Hoang T, Carstens JL, Zheng X, Wu CC, Simpson TR, Laklai H, Sugimoto H, Kahlert C, Novitskiy SV, De Jesus-Acosta A, Sharma P, Heidari P, Mahmood U, Chin L, Moses HL, Weaver VM, Maitra A, Allison JP, LeBleu VS, Kalluri R. 2014. Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. Cancer Cell 25:719-734.
33. Parast MM, Otey CA. 2000. Characterization of palladin, a novel protein localized to stress fibers and cell adhesions. J Cell Biol 150:643-656.
34. Rhim AD, Oberstein PE, Thomas DH, Mirek ET, Palermo CF, Sastra SA, Dekleva EN, Saunders T, Becerra CP, Tattersall IW, Westphalen CB, Kitajewski J, Fernandez-Barrena MG, Fernandez-Zapico ME, Iacobuzio-Donahue C, Olive KP, Stanger BZ. 2014. Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma. Cancer Cell 25:735-747.
35. Ronty MJ, Leivonen SK, Hinz B, Rachlin A, Otey CA, Kahari VM, Carpen OM. 2006. Isoform-specific regulation of the actin-organizing protein palladin during TGF-beta1-induced myofibroblast differentiation. J Invest Dermatol 126:2387-2396.
36. Salaria SN, Illei P, Sharma R, Walter KM, Klein AP, Eshleman JR, Maitra A, Schulick R, Winter J, Ouellette MM, Goggins M, Hruban R. 2007. Palladin is overexpressed in the non-neoplastic stroma of infiltrating ductal adenocarcinomas of the pancreas, but is only rarely overexpressed in neoplastic cells. Cancer Biol Ther 6:324-328.
37. Tabas-Madrid D, Nogales-Cadenas R, Pascual-Montano A. 2012. GeneCodis3: a non-redundant and modular enrichment analysis tool for functional genomics. Nucleic Acids Res 40:W478-W483.
38. Xie C, Mao X, Huang J, Ding Y, Wu J, Dong S, Kong L, Gao G, Li CY, Wei L. 2011. KOBAS 2.0: a web server for annotation and identification of enriched pathways and diseases. Nucleic Acids Res 39:W316-W322.